DUBLIN, Ireland -- Biotechnology firm Fixed Phage (PG) -- which works with industry partners to develop bacteria-killing products using its patented processes -- is close to commercial agreements on treatments for a number of species, commercial director Athol Haas told Undercurrent News [...]
Want to keep reading?
Sign up for a trial to have access to our articles!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.